Cargando…

MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake?

Background: (68)Ga DOTATATE PET/CT ((68)Ga-PET) has been proposed as a superior method in identifying ectopic ACTH syndrome (EAS). However, recent systematic review suggests its sensitivity is not as high as believed (1). We report a challenging case of EAS whose source was uncovered only after repe...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrade, Natália Xavier S, Pereira, Ana Julia Garcia, Villares Fragoso, Maria Candida Barisson, Bronstein, Marcello Delano, Machado, Marcio Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209597/
http://dx.doi.org/10.1210/jendso/bvaa046.264
_version_ 1783531115296849920
author Andrade, Natália Xavier S
Pereira, Ana Julia Garcia
Villares Fragoso, Maria Candida Barisson
Bronstein, Marcello Delano
Machado, Marcio Carlos
author_facet Andrade, Natália Xavier S
Pereira, Ana Julia Garcia
Villares Fragoso, Maria Candida Barisson
Bronstein, Marcello Delano
Machado, Marcio Carlos
author_sort Andrade, Natália Xavier S
collection PubMed
description Background: (68)Ga DOTATATE PET/CT ((68)Ga-PET) has been proposed as a superior method in identifying ectopic ACTH syndrome (EAS). However, recent systematic review suggests its sensitivity is not as high as believed (1). We report a challenging case of EAS whose source was uncovered only after repeated (68)Ga-PET. Clinical Case: A 15‐year-old male presented with rapid onset of typical features of Cushing’s syndrome (CS) and metabolic impairment. Hormone evaluation confirmed severe ACTH-dependent CS. Pituitary transsphenoidal surgery was performed due to positive responses in desmopressin stimulation and high dose dexamethasone suppression test, in addition to a 4 mm nodule in pituitary MRI. No tumor was found in surgical specimen and no hormonal improvement was observed after surgery. Inferior petrosal sinus sampling demonstrated no central to peripheral ACTH gradient. Neck US, thorax/abdomen/pelvis CT were negative and PET-CT/FDG was inconclusive. OctreoScan(®) identified anomalous uptake on left mediastinum and led the patient to a thoracic surgery (TS) with nodule resection at left hilum. Pathology confirmed ACTH positive 10 mm neuroendocrine tumor (NET) infiltrating a lymph node. The patient had transient clinical and hormonal improvement, with recurrence 7 months later. Thoracic CT (T-CT) showed a 7 mm nodule on inferior segment of superior left lobe, PET-CT/FDG and OctreoScan(®) were negative but abnormal uptake was verified by (68)Ga-PET in subcarinal area. A sub centimetric lymph node was resected and pathology confirmed ACTH positive NET, although the patient did not achieve remission. Octreotide LAR, cabergoline and ketoconazole did not control hypercortisolism and bilateral adrenalectomy was performed. Then, T-CT showed stable lung nodule and 2(nd 68)Ga-PET was negative. One year later, T-CT evidenced growth of lung nodule to 15 mm and 3(rd 68)Ga-PET demonstrated for the first time, abnormal uptake in this area. The patient underwent resection of left superior lung lobe along with ipsilateral hilar lymph nodes, and histopathology study revealed an ACTH-secreting atypical pulmonary carcinoid tumor with Ki67 of 10% and 5 out of 11 lymph nodes affected. ACTH fell from 288 to 64 pg/mL after surgery. Conclusion: Despite the high sensitivity attributed to (68)Ga-PET, false negatives have been reported. In the present case, primary tumor was evidenced by (68)Ga-PET seven years after the first resection of a metastatic lymph node, in the 3(rd 68)Ga-PET assessment and after tumor growth. This adds to the evidence that further studies are needed to better assess the accuracy of (68)Ga-PET for EAS. Reference: [1] Varlamov et al. Diagnostic utility of Gallium‐68‐somatostatin receptor PET/CT in ectopic ACTH‐secreting tumors: a systematic literature review and single‐center clinical experience. Pituitary 2019; 22:445–455
format Online
Article
Text
id pubmed-7209597
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72095972020-05-13 MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake? Andrade, Natália Xavier S Pereira, Ana Julia Garcia Villares Fragoso, Maria Candida Barisson Bronstein, Marcello Delano Machado, Marcio Carlos J Endocr Soc Neuroendocrinology and Pituitary Background: (68)Ga DOTATATE PET/CT ((68)Ga-PET) has been proposed as a superior method in identifying ectopic ACTH syndrome (EAS). However, recent systematic review suggests its sensitivity is not as high as believed (1). We report a challenging case of EAS whose source was uncovered only after repeated (68)Ga-PET. Clinical Case: A 15‐year-old male presented with rapid onset of typical features of Cushing’s syndrome (CS) and metabolic impairment. Hormone evaluation confirmed severe ACTH-dependent CS. Pituitary transsphenoidal surgery was performed due to positive responses in desmopressin stimulation and high dose dexamethasone suppression test, in addition to a 4 mm nodule in pituitary MRI. No tumor was found in surgical specimen and no hormonal improvement was observed after surgery. Inferior petrosal sinus sampling demonstrated no central to peripheral ACTH gradient. Neck US, thorax/abdomen/pelvis CT were negative and PET-CT/FDG was inconclusive. OctreoScan(®) identified anomalous uptake on left mediastinum and led the patient to a thoracic surgery (TS) with nodule resection at left hilum. Pathology confirmed ACTH positive 10 mm neuroendocrine tumor (NET) infiltrating a lymph node. The patient had transient clinical and hormonal improvement, with recurrence 7 months later. Thoracic CT (T-CT) showed a 7 mm nodule on inferior segment of superior left lobe, PET-CT/FDG and OctreoScan(®) were negative but abnormal uptake was verified by (68)Ga-PET in subcarinal area. A sub centimetric lymph node was resected and pathology confirmed ACTH positive NET, although the patient did not achieve remission. Octreotide LAR, cabergoline and ketoconazole did not control hypercortisolism and bilateral adrenalectomy was performed. Then, T-CT showed stable lung nodule and 2(nd 68)Ga-PET was negative. One year later, T-CT evidenced growth of lung nodule to 15 mm and 3(rd 68)Ga-PET demonstrated for the first time, abnormal uptake in this area. The patient underwent resection of left superior lung lobe along with ipsilateral hilar lymph nodes, and histopathology study revealed an ACTH-secreting atypical pulmonary carcinoid tumor with Ki67 of 10% and 5 out of 11 lymph nodes affected. ACTH fell from 288 to 64 pg/mL after surgery. Conclusion: Despite the high sensitivity attributed to (68)Ga-PET, false negatives have been reported. In the present case, primary tumor was evidenced by (68)Ga-PET seven years after the first resection of a metastatic lymph node, in the 3(rd 68)Ga-PET assessment and after tumor growth. This adds to the evidence that further studies are needed to better assess the accuracy of (68)Ga-PET for EAS. Reference: [1] Varlamov et al. Diagnostic utility of Gallium‐68‐somatostatin receptor PET/CT in ectopic ACTH‐secreting tumors: a systematic literature review and single‐center clinical experience. Pituitary 2019; 22:445–455 Oxford University Press 2020-05-08 /pmc/articles/PMC7209597/ http://dx.doi.org/10.1210/jendso/bvaa046.264 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Neuroendocrinology and Pituitary
Andrade, Natália Xavier S
Pereira, Ana Julia Garcia
Villares Fragoso, Maria Candida Barisson
Bronstein, Marcello Delano
Machado, Marcio Carlos
MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake?
title MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake?
title_full MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake?
title_fullStr MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake?
title_full_unstemmed MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake?
title_short MON-250 Late Diagnosis of ACTH-secreting Pulmonary Neuroendocrine Tumor by Repeated (68)Ga Dotatate Pet/ct: Influence of Tumor Size in Abnormal Uptake?
title_sort mon-250 late diagnosis of acth-secreting pulmonary neuroendocrine tumor by repeated (68)ga dotatate pet/ct: influence of tumor size in abnormal uptake?
topic Neuroendocrinology and Pituitary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209597/
http://dx.doi.org/10.1210/jendso/bvaa046.264
work_keys_str_mv AT andradenataliaxaviers mon250latediagnosisofacthsecretingpulmonaryneuroendocrinetumorbyrepeated68gadotatatepetctinfluenceoftumorsizeinabnormaluptake
AT pereiraanajuliagarcia mon250latediagnosisofacthsecretingpulmonaryneuroendocrinetumorbyrepeated68gadotatatepetctinfluenceoftumorsizeinabnormaluptake
AT villaresfragosomariacandidabarisson mon250latediagnosisofacthsecretingpulmonaryneuroendocrinetumorbyrepeated68gadotatatepetctinfluenceoftumorsizeinabnormaluptake
AT bronsteinmarcellodelano mon250latediagnosisofacthsecretingpulmonaryneuroendocrinetumorbyrepeated68gadotatatepetctinfluenceoftumorsizeinabnormaluptake
AT machadomarciocarlos mon250latediagnosisofacthsecretingpulmonaryneuroendocrinetumorbyrepeated68gadotatatepetctinfluenceoftumorsizeinabnormaluptake